We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Impact of Fructose-Containing Beverages and Foods from Childhood to Adulthood on Hypertension Risk: Evidence from the GUTS Cohort

MedXY Editorial Team•Jun 24, 2026•Cardiology
fructosefruit intakeHypertensionsugar-sweetened beverages

Highlight

– High intake of sugar-sweetened beverages (SSBs) and fruit juices is associated with increased risk of developing hypertension from childhood through adulthood.
– Whole fruit consumption does not increase hypertension risk and may reduce it when substituted for SSBs or fruit juice.
– Replacement of one daily serving of SSB or fruit juice with whole fruit, milk, or water lowers the risk of hypertension significantly.
– These findings support public health initiatives to limit sugary beverage consumption starting early in life to prevent hypertension.

Study Background

Hypertension is a major public health concern worldwide, contributing substantially to cardiovascular morbidity and mortality. Its origins increasingly trace back to early life dietary exposures. Consumption of high fructose-containing sugars, particularly from sugar-sweetened beverages (SSBs), has been implicated in the pathogenesis of obesity and hypertension. However, fructose intake from different sources, such as fruit juices and whole fruits, involves varying nutritional compositions and food matrices that may differently influence blood pressure regulation. There remains a crucial need to clarify how these major fructose sources across childhood and adulthood impact the long-term risk of hypertension to inform effective dietary recommendations.

Study Design

This study utilizes data from the Growing Up Today Study (GUTS), a large prospective cohort comprising 25,749 participants (55% female) enrolled in two waves: GUTS 1 (n=16,875; baseline 1996) and GUTS II (n=10,918; baseline 2004). Participants were followed for up to 25 years, with baseline mean age of 12 years and mean age at end of follow-up 36 years. Dietary intake was assessed repeatedly every 1 to 4 years using validated food frequency questionnaires to track consumption of total fructose, sugar-sweetened beverages, fruit juice, and whole fruit. Incident hypertension diagnosis was self-reported and validated when possible. The study employed multivariable-adjusted Cox proportional hazards regression models to estimate hazard ratios (HRs) for incident hypertension by quintiles or categories of fructose-containing food and beverage intake. Major confounders including diet quality, physical activity, BMI, and lifestyle factors were adjusted. Substitution models evaluated the impact of replacing SSBs or fruit juice with whole fruit, milk, or water on hypertension risk.

Key Findings

During the mean follow-up period extending up to 25 years, 1,625 participants (6.3%) developed hypertension. Analysis revealed that total fructose intake per se was not significantly associated with incident hypertension when comparing the highest versus lowest quintile (HR 1.07; 95% CI, 0.92 to 1.25; statistically significant trend but no substantial risk elevation). In contrast, higher consumption of SSBs (≥2 servings/day vs. <3 servings/week) was strongly associated with increased risk of developing hypertension (HR 1.52; 95% CI, 1.27 to 1.83; Ptrend <0.001). Similarly, higher fruit juice intake (≥1.5 servings/day vs. <1 serving/week) showed an elevated hypertension risk (HR 1.35; 95% CI, 1.06 to 1.71; Ptrend =0.018). Whole fruit intake was linked to a non-significant trend toward reduced risk (HR 0.79 in highest vs. lowest category; 95% CI, 0.59 to 1.05; Ptrend=0.08).

Substitution analyses demonstrated that replacing one serving per day of SSB with milk, water, or whole fruit corresponded to 13% (95% CI, 5%–20%), 9% (95% CI, 3%–15%), and 22% (95% CI, 11%–31%) lower risks of hypertension, respectively. Moreover, replacing fruit juice with whole fruit was associated with a 19% reduction in risk (95% CI, 3%–32%). These substitutions highlight the potential benefits of modifying beverage and fruit consumption patterns as a strategy for hypertension prevention starting early in life.

Expert Commentary

This longitudinal cohort study adds valuable evidence to the growing literature on the differential impact of fructose-containing food and beverage sources on hypertension risk. The disparity in effects between sugar-sweetened beverages and whole fruits underlines the critical role of the food matrix and associated nutrients such as fiber, vitamins, and bioactive compounds found in whole fruits that may counteract adverse metabolic effects. The positive associations with SSBs and fruit juice support biological plausibility involving fructose-induced mechanisms like increased uric acid production, insulin resistance, and sodium retention leading to elevated blood pressure. Notably, the findings remain robust after adjustment for numerous confounders and lifestyle factors.

Limitations include reliance on self-reported hypertension outcomes, although regular follow-up and validated questionnaires strengthen reliability. Despite these limitations, the large sample size, long follow-up, and repeated dietary assessment enhance generalizability and temporal inference. Future research might explore mechanistic biomarker endpoints or randomized controlled trials of substitution interventions.

Conclusion

This prospective study robustly demonstrates that sustained high intake of sugar-sweetened beverages and fruit juices from childhood into adulthood increases the risk of developing hypertension, whereas whole fruit consumption does not confer this risk and may provide protective effects. Modifying dietary habits by substituting SSBs and fruit juices with whole fruit, milk, or water significantly lowers hypertension risk. These findings underline the critical importance of early dietary interventions to curb the rising burden of hypertension and cardiovascular disease.

Public health guidelines should emphasize limiting consumption of sugar-sweetened beverages and fruit juice beginning in childhood to protect long-term cardiovascular health. Clinicians should counsel patients and families on healthier beverage choices to prevent the development of hypertension. Further confirmatory and mechanistic studies may refine these recommendations and support policy measures to reduce added sugar consumption nationally and globally.

Funding and ClinicalTrials.gov

The study was supported by funding from [funding sources, if applicable]. The GUTS cohort details can be accessed via ClinicalTrials.gov identifier: [not specified in provided text].

References

Nguyen M, AlEssa HB, Glenn AJ, Tobias DK, Chavarro JE, Willett WC, Hu FB, Hanley AJ, Birken CS, Sievenpiper JL, Malik VS. Consumption of Fructose-Containing Food and Beverage Sources in Childhood Through to Adulthood and Risk of Hypertension: A Prospective Cohort Study. Circulation. 2026 Jun 22; PMID: 42324999.

Additional references:
1. Malik VS, et al. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010.
2. Elliott P, Hu FB. Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol. 2015.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension ManagementRecent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.Sep 17, 2026Impact of an AI-Powered Gamified Mobile Health Application on Blood Pressure Control in a Matched Patient CohortStudy found that use of an AI-driven gamified mobile app integrating home blood pressure monitoring significantly improved blood pressure control compared to usual care in hypertensive patients.Sep 17, 2026Sustained Reduction of Severe Maternal Morbidity and Racial Disparities Through a Statewide Perinatal Quality CollaborativeA Louisiana statewide perinatal quality collaborative significantly reduced severe maternal morbidity related to hemorrhage and hypertension, sustained improvements across initiatives, and narrowed racial disparities, demonstrating durableSep 8, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Sustained Cardiovascular Benefits of Intensive Blood Pressure Management Led by Nonphysician Providers: 7-Year Follow-Up of the CRHCP Trial
Long-term intensive BP control led by trained nonphysician community providers significantly lowers cardiovascular risk over 7 years, with benefits persisting 3 years post-intervention in rural China.
Aug 29, 2026
Impact of a Community- and Family-Based Intervention on Blood Pressure Reduction in Rural China: Insights from a Cluster-Randomized TrialThis cluster-randomized trial in rural China demonstrates that a coordinated community- and family-based intervention effectively lowers systolic blood pressure at the population level, highlighting the importance of sustained community engAug 28, 2026
Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive ReviewThis review synthesizes evidence on physician-focused financial incentives for hypertension control, highlighting nuanced impacts on clinical decisions, documented blood pressure control, and cardiovascular outcomes, with a focus on both ovAug 18, 2026